• 41
  • 6
  • 收藏

Biogen plans to submit final design of Aduhelm confirmatory trial to FDA in March

Reuters2021-12-16

Biogen Inc said on Thursday it was expecting to submit a final design for a post-marketing confirmatory study of its newly approved Alzheimer's drug, Aduhelm, to the U.S. Food and Drug Administration ...

网页链接

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

举报

评论6

  • Ruby Kes
    ·2021-12-17
    Bring in the FDA and bomb everything goes up.
    回复
    举报
  • TradeMore
    ·2021-12-16
    Ok
    回复
    举报
  • JoshuaLiew
    ·2021-12-16
    Ok can can
    回复
    举报
  • ShieYing
    ·2021-12-16
    Pls like
    回复
    举报
  • Lzoakz
    ·2021-12-16
    Ok
    回复
    举报
    收起
    • Lgdnic
      Ok
      2021-12-16
      回复
      举报
    • ShieYing
      ok
      2021-12-16
      回复
      举报
    • Angsana
      ok
      2021-12-16
      回复
      举报
  • frusty
    ·2021-12-16
    Like
    回复
    举报
    收起
    • Lzoakz
      Ok
      2021-12-16
      回复
      举报
 
 
 
 

热议股票

 
 
 
 
 

7x24